⌘K

Home/Filings/4/0000819050-22-000048

4//SEC Filing

Breton Jose 4

Accession 0000819050-22-000048

CIK 0000819050other

View on SEC.gov Company Profile

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:17 PM ET

Size

5.5 KB

Accession

0000819050-22-000048

Insider Transaction Report

Form 4

Period: 2022-05-05

Brickell Biotech, Inc.BBI

Chief Accounting Officer

Transactions

Award
Stock Option (right to buy)
2022-05-05+150,000→ 150,000 total
Exercise: $0.26From: 2023-05-05Exp: 2032-05-05→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.

Documents

1 file

4
wf-form4_165212743045735.xmlPrimary
FORM 4

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001784373

Filing Metadata

Form type: 4
Filed: May 8, 8:00 PM ET
Accepted: May 9, 4:17 PM ET
Size: 5.5 KB

View on SEC.gov